News
Article
Author(s):
In case you missed it, this week we had news about phase 2b enrollment for VYNE’s vitiligo gel, the impact of anti-inflammatory moisturizers for AD, the newly FDA-approved DermiSphere hDRT, and more.
To stay up-to-date with the latest dermatology news, sign up to receive our eNewsletters.
FDA Proposes Mandatory Asbestos Testing for Talc-Containing Cosmetics
The FDA recently proposed a new rule requiring standardized asbestos testing in talc-containing cosmetics to protect consumers from potential harm.
The Impact of Anti-Inflammatory Moisturizers in Mild to Moderate Atopic Dermatitis Treatment
More improved skin hydration and barrier function was observed in moisturizers with anti-inflammatory ingredients, compared to those without.
Quoin Pharmaceuticals’ Announces Positive Interim QRX003 Data for Netherton Syndrome
The results showed promising improvements in all endpoints with high patient satisfaction and no safety concerns.
VYNE Completes Phase 2b Enrollment for Vitiligo Gel
Repibresib’s localized delivery minimizes systemic exposure while targeting inflammatory pathways, a novel approach for vitiligo management.
POLL: Which Anticipated Drug Approval/PDUFA Date Are You Most Looking Forward to in 2025?
Share your insights and anticipation with us.
The HA filler with tri-hyal technology reduced wrinkles on the forehead, upper lip, cheek folds, and crow’s feet for up to 18 months.
Introducing Dermatology Times’ 2025 Editor in Chief
Christopher Bunick, MD, PhD, is an associate professor of dermatology and physician-scientist at Yale School of Medicine in New Haven, Connecticut.
Current Evidence is Inadequate in Proving the Benefits of Herbal Remedies on Melasma
With further research, plants such as licorice, tomato, and parsley, could eventually be promising alternatives for melasma patients.
Blisters, Chafing, and More: Common Skin Conditions for Runners
By addressing skin health proactively, runners can enhance performance and longevity in the sport while minimizing discomfort and long-term dermatological damage.
Thinking Outside the Psoriatic Box: Practical Points for Systemic Success
Explore systemic psoriasis management, covering obesity, depression, biologics, and innovative treatment approaches.
Novel Water-Soluble CoQ10 Serum Shows Promising Results for Anti-Aging
The stable preparation combined vitamin C and hyaluronic acid with complexed ubiquinone in this initial study.
The Relationships Between Vitamin D, Zinc, and Seborrheic Dermatitis
While zinc deficiency shows strong ties to SD, researchers stated vitamin D's role is less clear and may depend on genetic factors.
A Finnish review highlights imprecise use of L23.8 and L23.9 codes for allergic contact dermatitis, impacting data accuracy and patient care.
Unveiling the Complexities of Atopic Dermatitis Care
Experts explore innovative therapies, psychosocial impacts, and education strategies for managing atopic dermatitis in a Dermatology Times video series.
Palvella begins its phase 2 TOIVA trial of Qtorin rapamycin gel for cutaneous venous malformations, targeting the mTOR pathway.
Combination Treatment of Cryolipolysis and Hyaluronic Acid Fillers Greatly Enhances Jawline
The synergistic approach reduced submental fullness, enhanced mandible line definition, and improved chin projection.
Ionic Liquids Boost Skin Drug Delivery
The innovative technology is unlocking new possibilities in dermatology by improving the solubility and permeability of drugs for topical use.
FDA Approves Collagen-Based DermiSphere Hydrogel
Designed to mimic natural tissue scaffolds, DermiSpherehDRT offers innovative support for cellular infiltration and healing in reconstructive surgery.
BioStem Launches BR-AM-DFU Clinical Trial for Non-Healing Diabetic Foot Ulcers
The company is currently recruiting participants to demonstrate the benefits of its BioREtain technology.
UVF Dermoscopy Performs Best Alongside Polarized Light Examination in Scabies Detection
UVF dermoscopy enhances scabies detection, especially in dark skin, with optimal results when combined with polarized light examination.
Next-Gen Therapy: Advancing Topical Therapeutics
Mitragotri said new innovations like ionic liquid-based delivery systems can offer better treatment for immunodermatological conditions.
Fractional Radiofrequency Microneedling is a Safe Monotherapy for Acne Scarring
A recent systemic review found FRM to be an effective treatment modality on its own for managing facial acne scars.
DFD-29: The Journey to FDA Approval and a New Era in Rosacea Management
DFD-29, FDA-approved in 2024, revolutionizes rosacea management by addressing both erythema and inflammatory lesions with a novel extended-release formulation.
ICYMI: Eirion ET-02’s Successful Phase 1 Trial Results for Androgenic Alopecia Treatment
The 5% dosage showed a 6-fold increase in non-vellus hair count after just 5 weeks.
Ruxolitinib Cream Shows Strong Efficacy in Max-Use Pediatric Trial
A study revealed ruxolitinib cream's rapid, lasting benefits in pediatric eczema without systemic safety concerns over a 52-week trial period.
The recommendations place an emphasis on the utility of ultrasound-guided placement to enhance safety.
State-of-the-State Update: Chronic Hand Eczema
Chronic hand eczema poses diagnostic and treatment challenges due to its multifaceted etiology. New therapies like JAK inhibitors offer hope.
Study Reveals Immune Checkpoint Inhibitor Treatment and Monitoring Practices Post-Remission
Post treatment discontinuation, most centers conduct imaging every 3 months during the first year of remission.
Nektar Therapeutics Completes Enrollment for Phase 2b REZOLVE-AD Trial of Rezpegaldesleukin
Rezpegaldesleukin, a novel IL-2 receptor agonist, enters phase 2b evaluation for atopic dermatitis, aiming to advance therapeutic options for this chronic condition.
730-nm Picosecond Laser Can Be Used to Treat Freckles, Novel Study Finds
Patients saw an average clearance rate of 74.46% after just 1 session of laser therapy.
Bridging Therapeutic Innovation and Dermatology
Advancements in therapeutic agents demand innovative strategies for safe, localized skin treatments, Mitragotri argues.
Anti-Wrinkle Cream Containing Horsetail and Soybean is Stable and Efficacious
93.4% of patients saw a positive change in the appearance of forehead wrinkles after 8 weeks of use.
Reflecting on the Growth of NPs and PAs in Dermatology
At the inaugural Horizons in Advanced Practice meeting, Lakshi Aldredge, MSN, ANP-BC, reviewed complex cases on AD and PsO and the role of PAs and NPs in advancing patient care.
Top 5 Articles of the Week: January 5-10
Explore the top headlines of the week including clinical trial updates, FDA announcements, and expert insights.